The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Replicating and non-replicating viral vectors for vaccine development
Open accessAbstract
Viral vectors provide a convenient means to deliver vaccine antigens to select target cells or tissues. A broad spectrum of replicating and non-replicating vectors is available. An appropriate choice for select applications will depend on the biology of the infectious agent targeted, as well as factors such as whether the vaccine is intended to prevent infection or boost immunity in already infected individuals, prior exposure of the target population to the vector, safety, and the number and size of gene inserts needed. Here several viral vectors under development as HIV/AIDS vaccines are reviewed. A vaccine strategy based on initial priming with a replicating vector to enlist the innate immune system, target mucosal inductive sites, and prime both cellular and humoral systemic and mucosal immune responses is proposed. Subsequently, boosting with a replicating or non-replicating vector and/or protein subunits could lead to induction of necessary levels of protective immunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,336
Shiver, J. W., Fu, T.-M., Chen, L., Casimiro, D. R., Davies, M.-E., Evans, R. K., Zhang, Z.-Q., Simon, A. J., Trigona, W. L., Dubey, S. A., et al. (2002) · Nature · doi:10.1038/415331a · Cited by 1,176
Control of a Mucosal Challenge and Prevention of AIDS by a Multiprotein DNA/MVA Vaccine
Amara, R. R. (2001) · Science · doi:10.1126/science.1058915 · Cited by 1,106
Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses
Jones, S. M., Feldmann, H., Ströher, U., Geisbert, J. B., Fernando, L., Grolla, A., Klenk, H.-D., Sullivan, N. J., Volchkov, V. E., Fritz, E. A., et al. (2005) · Nature Medicine · doi:10.1038/nm1258 · Cited by 687
Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity
Roberts, D. M., Nanda, A., Havenga, M. J. E., Abbink, P., Lynch, D. M., Ewald, B. A., Liu, J., Thorner, A. R., Swanson, P. E., Gorgone, D. A., et al. (2006) · Nature · doi:10.1038/nature04721 · Cited by 491
An Effective AIDS Vaccine Based on Live Attenuated Vesicular Stomatitis Virus Recombinants
Rose, N. F., Marx, P. A., Luckay, A., Nixon, D. F., Moretto, W. J., Donahoe, S. M., Montefiori, D., Roberts, A., Buonocore, L., & Rose, J. K. (2001) · Cell · doi:10.1016/s0092-8674(01)00482-2 · Cited by 440
Samaniego, L. A., Neiderhiser, L., & DeLuca, N. A. (1998) · Journal of Virology · doi:10.1128/jvi.72.4.3307-3320.1998 · Cited by 372
Preserved CD4+ Central Memory T Cells and Survival in Vaccinated SIV-Challenged Monkeys
Letvin, N. L., Mascola, J. R., Sun, Y., Gorgone, D. A., Buzby, A. P., Xu, L., Yang, Z.-Y., Chakrabarti, B., Rao, S. S., Schmitz, J. E., et al. (2006) · Science · doi:10.1126/science.1124226 · Cited by 372
Catanzaro, A. T., Koup, R. A., Roederer, M., Bailer, R. T., Enama, M. E., Moodie, Z., Gu, L., Martin, J. E., Novik, L., Chakrabarti, B. K., et al. (2006) · The Journal of Infectious Diseases · doi:10.1086/509258 · Cited by 321
Gómez-Román, V. R., Patterson, L. J., Venzon, D., Liewehr, D., Aldrich, K., Florese, R., & Robert-Guroff, M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.4.2185 · Cited by 276
Self-citationCasimiro, D. R., Wang, F., Schleif, W. A., Liang, X., Zhang, Z.-Q., Tobery, T. W., Davies, M.-E., McDermott, A. B., O'Connor, D. H., Fridman, A., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.24.15547-15555.2005 · Cited by 271
HIV vaccine design: insights from live attenuated SIV vaccines
Koff, W. C., Johnson, P. R., Watkins, D. I., Burton, D. R., Lifson, J. D., Hasenkrug, K. J., McDermott, A. B., Schultz, A., Zamb, T. J., Boyle, R., et al. (2006) · Nature Immunology · doi:10.1038/ni1296 · Cited by 256
Tatsis, N., Fitzgerald, J. C., Reyes-Sandoval, A., Harris-McCoy, K. C., Hensley, S. E., Zhou, D., Lin, S.-W., Bian, A., Xiang, Z. Q., Iparraguirre, A., et al. (2007) · Blood · doi:10.1182/blood-2007-02-062117 · Cited by 218
Vaccination preserves CD4 memory T cells during acute simian immunodeficiency virus challenge
Mattapallil, J. J., Douek, D. C., Buckler-White, A., Montefiori, D., Letvin, N. L., Nabel, G. J., & Roederer, M. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060657 · Cited by 184
Patterson, L. J., Malkevitch, N., Venzon, D., Pinczewski, J., Gómez-Román, V. R., Wang, L., Kalyanaraman, V. S., Markham, P. D., Robey, F. A., & Robert-Guroff, M. (2004) · Journal of Virology · doi:10.1128/jvi.78.5.2212-2221.2004 · Cited by 172
Self-citationPerri, S., Greer, C. E., Thudium, K., Doe, B., Legg, H., Liu, H., Romero, R. E., Tang, Z., Bin, Q., Dubensky, T. W., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.19.10394-10403.2003 · Cited by 172
Neurovirulence properties of recombinant vesicular stomatitis virus vectors in non-human primates
Johnson, J. E., Nasar, F., Coleman, J. W., Price, R. E., Javadian, A., Draper, K., Lee, M., Reilly, P. A., Clarke, D. K., Hendry, R. M., et al. (2007) · Virology · doi:10.1016/j.virol.2006.10.026 · Cited by 160
Herremans, T. M. P. T., Reimerink, J. H. J., Buisman, A. M., Kimman, T. G., & Koopmans, M. P. G. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.8.5011 · Cited by 149
Smallpox vaccines: Past, present, and future
Parrino, J., & Graham, B. S. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.09.037 · Cited by 145
Use of viral vectors for the development of vaccines
Liniger, M., Zúñiga, A., & Naim, H. Y. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.2.255 · Cited by 143
Lorin, C., Mollet, L., Delebecque, F., Combredet, C., Hurtrel, B., Charneau, P., Brahic, M., & Tangy, F. (2003) · Journal of Virology · doi:10.1128/jvi.78.1.146-157.2004 · Cited by 128
Hanke, T., McMichael, A. J., & Dorrell, L. (2006) · Journal of General Virology · doi:10.1099/vir.0.82493-0 · Cited by 119
Thorner, A. R., Vogels, R., Kaspers, J., Weverling, G. J., Holterman, L., Lemckert, A. A. C., Dilraj, A., McNally, L. M., Jeena, P. M., Jepsen, S. V., et al. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.01249-06 · Cited by 113
Peng, B., Wang, L. R., Román, R. G., Davis‐Warren, A., Montefiori, D. C., Kalyanaraman, V. S., Venzon, D. J., Zhao, J., Kan, E., Rowell, T. J., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.16.10200-10209.2005 · Cited by 107
Self-citationPhase 2 Study of an HIV-1 Canarypox Vaccine (vCP1452) Alone and in Combination With rgp120
Russell, N. D., Graham, B. S., Keefer, M. C., McElrath, M. J., Self, S. G., Weinhold, K. J., Montefiori, D. C., Ferrari, G., Horton, H., Tomaras, G. D., et al. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000248356.48501.ff · Cited by 105
Biology and application of alphaviruses in gene therapy
Lundstrom, K. H. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302620 · Cited by 100
Franchini, G., Gurunathan, S., Baglyos, L., Plotkin, S. A., & Tartaglia, J. (2004) · Expert Review of Vaccines · doi:10.1586/14760584.3.4.s75 · Cited by 97
Johnson, P. R., Schnepp, B. C., Connell, M. J., Rohne, D., Robinson, S., Krivulka, G. R., Lord, C. I., Zinn, R. L., Montefiori, D. C., Letvin, N. L., et al. (2004) · Journal of Virology · doi:10.1128/jvi.79.2.955-965.2005 · Cited by 96
Chimpanzee-origin adenovirus vectors as vaccine carriers
Tatsis, N., Tesema, L., Robinson, E., Giles‐Davis, W., McCoy, K., Gao, G., Wilson, J. M., & Ertl, H. C. J. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302675 · Cited by 95
Gómez, C. E., Nájera, J. L., Pérez-Jiménez, E., Jiménez, V., Wagner, R., Graf, M., Frachette, M.-J., Liljeström, P., Pantaleo, G., & Estéban, M. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.09.090 · Cited by 94
Alphavirus Replicon Particles as Candidate HIV Vaccines
Davis, N., West, A., Reap, E. A., MacDonald, G. H., Collier, M., Dryga, S. A., Maughan, M. F., Connell, M. J., Walker, C., McGrath, K., et al. (2002) · IUBMB Life · doi:10.1080/15216540212657 · Cited by 86
Attenuated measles virus as a vaccine vector
Zúñiga, A., Wang, Z., Liniger, M., Hangartner, L., Caballero, M., Pavlovic, J., Wild, P., Viret, J. F., Glueck, R., Billeter, M. A., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.01.064 · Cited by 84
Demberg, T., Florese, R. H., Heath, M. J., Larsen, K., Kalisz, I., Kalyanaraman, V. S., Lee, E. M., Pal, R., Venzon, D. J., Grant, R., et al. (2007) · Journal of Virology · doi:10.1128/jvi.02453-06 · Cited by 84
Self-citationXin, K.-Q., Mizukami, H., Urabe, M., Toda, Y., Shinoda, K., Yoshida, A., Oomura, K., Kojima, Y., Ichino, M., Klinman, D., et al. (2006) · Journal of Virology · doi:10.1128/jvi.00890-06 · Cited by 81
Liang, X., Casimiro, D. R., Schleif, W. A., Wang, F., Davies, M.-E., Zhang, Z., Fu, T., Finnefrock, A. C., Handt, L., Citron, M. P., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.19.12321-12331.2005 · Cited by 77
Kierstead, L. S., Dubey, S. A., Meyer, B. E., Tobery, T. W., Mogg, R., Fernandez, V. R., Long, R. S., Guan, L., Gaunt, C., Collins, K., et al. (2007) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2006.0129 · Cited by 75
Recombinant vesicular stomatitis virus as an HIV-1 vaccine vector
Clarke, D. K., Cooper, D., Egan, M. A., Hendry, R. M., Parks, C. L., & Udem, S. A. (2006) · Springer Seminars in Immunopathology · doi:10.1007/s00281-006-0042-3 · Cited by 74
Egan, M. A., Chong, S. Y., Megati, S., Montefiori, D. C., Rose, N. F., Boyer, J., Sidhu, M. K., Quiroz, J., Rosati, M., Schadeck, E. B., et al. (2005) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2005.21.629 · Cited by 73
Vaccines Based on Novel Adeno-Associated Virus Vectors Elicit Aberrant CD8+T-Cell Responses in Mice
Lin, J., Zhi, Y., Mays, L., & Wilson, J. M. (2007) · Journal of Virology · doi:10.1128/jvi.01253-07 · Cited by 66
Patterson, L. J., Malkevitch, N., Pinczewski, J., Venzon, D. J., Lou, Y., Peng, B., Munch, C., Leonard, M., Richardson, E. S., Aldrich, K., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.16.8607-8620.2003 · Cited by 62
Self-citationKaur, A., Sanford, H. B., Garry, D., Lang, S. M., Klumpp, S. A., Watanabe, D., Bronson, R. T., Lifson, J. D., Rosati, M., Pavlakis, G. N., et al. (2006) · Virology · doi:10.1016/j.virol.2006.08.007 · Cited by 59
Watanabe, D., Brockman, M. A., Ndung’u, T., Mathews, L. C., Lucas, W. T., Murphy, C. G., Felber, B. K., Pavlakis, G. N., DeLuca, N. A., & Knipe, D. M. (2006) · Virology · doi:10.1016/j.virol.2006.08.015 · Cited by 43
Development and application of replication-incompetent HSV-1-based vectors
Berto, E., Bozac, A., & Marconi, P. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302623 · Cited by 39
Xu, R., Srivastava, I. K., Greer, C. E., Zarkikh, I., Kraft, Z., Kuller, L., Polo, J. M., Barnett, S. W., & Stamatatos, L. (2006) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2006.22.1022 · Cited by 34
Greer, C. E., Zhou, F., Legg, H. S., Tang, Z., Perri, S., Sloan, B. A., Megede, J. Z., Uematsu, Y., Vajdy, M., & Polo, J. M. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.07.048 · Cited by 27
Replication-competent herpes simplex vectors: design and applications
Argnani, R., Lufino, M. M., Manservigi, M., & Manservigi, R. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302622 · Cited by 24
Gupta, S., Zhou, F., Greer, C. E., Legg, H. S., Tang, T., Luciw, P. A., Megede, J. Z., Barnett, S. W., Donnelly, J., O’Hagan, D. T., et al. (2006) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2006.22.993 · Cited by 14
Cited by
Nonviral delivery of self-amplifying RNA vaccines
Geall, A. J., Verma, A., Otten, G. R., Shaw, C. A., Hekele, A., Banerjee, K., Cu, Y., Beard, C. W., Brito, L. A., Krucker, T., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1209367109 · Cited by 741
DNA vaccines: an historical perspective and view to the future
Liu, M. A. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00980.x · Cited by 468
The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?
Sekaly, R.-P. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072681 · Cited by 400
A Comprehensive Review of the Global Efforts on COVID-19 Vaccine Development
Li, Y., Tenchov, R., Smoot, J., Liu, C., Watkins, S., & Zhou, Q. (2021) · ACS Central Science · doi:10.1021/acscentsci.1c00120 · Cited by 351
A Cationic Nanoemulsion for the Delivery of Next-generation RNA Vaccines
Brito, L. A., Chan, M., Shaw, C. A., Hekele, A., Carsillo, T., Schaefer, M., Archer, J., Seubert, A., Otten, G. R., Beard, C. W., et al. (2014) · Molecular Therapy · doi:10.1038/mt.2014.133 · Cited by 338
Metadata
- Authors
- Robert-Guroff, M.
- Venue
- Current Opinion in Biotechnology
- Publisher
- Elsevier BV
- Published
- 2007-12
- Volume
- 18
- Issue
- 6
- Pages
- 546-556
- ISSN
- 0958-1669 (ISSN-L)
- OpenAlex
- W1999004290
- Cited by
- 275
- References
- 47
- FWCI
- 0.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.